| milligrams | 10mg |
|---|
CJC-1295 (No DAC)
Research Grade Peptide
- Research Grade
- 99% Purity
- Third-Party Verified
Reference Strength: 10mg
R799,00
CAS: 863288-34-0
Formula: C152H252N44O42S
Molecular Weight: 3367.97
Chemical Name / Amino Acid Sequence: tyr-d-ala-asp-ala-ile-phe-thr-gln-ser-tyr-arg-lys-val-leu-ala-gln-leu-ser-ala-arg-lys-leu-leu-gln-asp-ile-leu-ser-arg-gln (GHRH 1-29 analogue; modified GRF)
Availability: In stock
SKU: CND10
CJC-1295 (No DAC)
R799,00
GHRH analogue — studied for growth hormone release and pituitary signalling
Availability: In stock
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About CJC-1295 (No DAC)
CJC-1295 is a growth hormone-releasing hormone that signals your pituitary gland to produce more natural growth hormone in pulsatile waves, mimicking your body's natural rhythm.
How It Works in Research
It extends the time your body's natural growth hormone pulse lasts, allowing for more sustained release without shutting down your natural production. This means more muscle growth, better fat burning, improved sleep, and enhanced recovery without the side effects of synthetic growth hormone.
Research Applications
Perfect for research into natural growth hormone optimization, anti-aging protocols, muscle growth, fat loss, sleep quality improvement, and athletic performance enhancement.
This is a simplified explanation for educational purposes. For detailed scientific information, see the Product Specifications section below.
Functional Performance Profile
Recovery Support
Hormonal Balance
Muscle Growth
Key Benefits
- Growth Hormone Support
- Muscle Development
- Enhanced Recovery
Product Specifications
- Purity: 99.6%
- Form: Lyophilized peptide
- Storage: 2-9°C Refrigerated
Research Information
- Type: GHRH analog
- Focus: Growth hormone production
Scientific Information
Research Reference Parameters — Laboratory Use Only
- Initial phase: 0.1 mg daily dose, 5 days on 2 days off.
- Standard research range: 0.2 mg once daily dose, 5 days on 2 days off.
- Advanced research range: 0.3 mg once daily dose, 5 days on 2 days off.
- Research cycles typically extend 8-12 weeks
For laboratory research only.
Mechanism of Action
CJC-1295 (No DAC) binds to GHRH receptors in the pituitary gland, extending the duration of natural GH pulses from ~30 minutes to 1-2 hours. This amplifies each natural GH release without creating constant elevation, preserving physiological rhythms.
Key Research Characteristics
GHRH Analog Without DAC
Modified growth hormone-releasing hormone that extends natural GH pulse duration without the Drug Affinity Complex, allowing for more natural pulsatile patterns and shorter half-life (30 minutes vs 6-8 days).
Preserves Natural Rhythms
Works with the body's circadian GH release patterns rather than creating sustained elevation, maintaining the natural peaks and troughs essential for receptor sensitivity.
No Negative Feedback Suppression
Doesn't suppress endogenous GH production or cause desensitization, making it suitable for long-term research protocols without loss of efficacy.
Potential Benefits in Research
Growth Hormone Optimization
- Increased natural GH pulse amplitude and duration
- Enhanced IGF-1 production and levels
- Improved GH/IGF-1 axis function
- Maintained receptor sensitivity over time
- Body Composition
- Increased lean muscle mass
- Reduced body fat percentage
- Improved muscle-to-fat ratio
- Enhanced protein synthesis markers
- Recovery & Anti-Aging
- Improved sleep quality (especially deep sleep)
- Enhanced recovery from training/injury
- Better skin quality and thickness
- Improved bone density markers
Safety Profile
Important: These side effects are reported from research studies and may vary by individual, dosage, and protocol. Always monitor subjects carefully and consult with qualified researchers.
Mild injection site reactions
- Water retention or mild bloating
- Transient headaches
- Flushing or warmth sensation
- Tingling or numbness in extremities (rare)
- Increased hunger in some subjects
- Rare: Temporary hyperglycemia
Research Applications
Natural GH optimization research
Anti-aging and longevity studies
Body composition optimization protocols
Sleep quality and recovery research
Athletic performance enhancement studies
Research Note: The information presented here is based on published scientific literature and research protocols. Individual results may vary based on research design, subject characteristics, and methodological approaches. Always conduct appropriate due diligence and follow institutional research guidelines.
REFERENCE RECONSTITUTION INFORMATION
This guide explains how research peptides are commonly reconstituted using bacteriostatic water (BAC water), and shows how dosing volumes correspond to syringe units. Always follow sterile preparation techniques when handling research peptides.
Always follow sterile preparation techniques when handling research peptides.
⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
General Preparation
⚠️ Important: Allow product vial and BAC water to reach room temperature before reconstituting to reduce condensation uptake
- Use bacteriostatic water (BAC water) only
- Inject water slowly down the inside of the vial
- Do not shake the vial
- Gently swirl to dissolve the peptide powder
- Store refrigerated after mixing
- Use sterile technique when handling
CJC-1295 (NO DAC) (10mg) - RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of CJC-1295 (No DAC).
- Route
- Subcutaneous injection
- Timing
- Before bedtime or post-workout
- Injection Sites
- Rotate injection sites (abdomen, thighs, upper arms)
- Use sterile technique when handling and administering
- Cycle Length: 8–12 weeks (extendable to 16 weeks)
- Goal: Support endogenous growth hormone release
Reference Parameters (Dosing Protocol (3ml BAC Water; 3.33 mg/ml))
| DOSE LEVEL | DOSE PER INJECTION | UNITS (PER INJECTION) (ML) |
|---|---|---|
| Low | 0.10 mg | 3 units (0.03ml) |
| Medium | 0.20 mg | 6 units (0.06ml) |
| High | 0.30 mg | 9 units (0.09ml) |
For laboratory research only.
Experimental Study Period
STUDY PERIOD
12–16 weeks
WASHOUT PERIOD
4–8 weeks
ADJUSTMENT NOTES
Not required
RESEARCH CONTEXT
Prevents GHRH receptor desensitisation and maintains growth hormone response
These tables show common research dosages. Always use an insulin syringe marked with units for accurate measurement. Contact our research support team for additional guidance.
View Certificate of Analysis
View Certificate of Analysis Each batch of CJC-1295 (No DAC) is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
99.6%
Verified Purity
3rd Party
Lab Tested
Certified
Quality Assured
Only logged in customers who have purchased this product may leave a review.
Related products
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
PURE PERFORMANCE LABS
Recommended Research Products
Explore related compounds commonly viewed alongside this product.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.
Reviews
There are no reviews yet.